Our experience of treating adult bone lymphoma, A retrospective cross-sectional study in a tertiary care center, Aga Khan University Hospital, Karachi

To determine the experience at the Aga Khan University Hospital in diagnosing and treating adult patients with primary lymphoma of bone. All patients with Primary lymphoma of bone (PLB) that were diagnosed and/or treated at Aga Khan University Hospital, Karachi from 2005 to 2019 were included as par...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the Pakistan Medical Association 2021-08, Vol.71(Suppl 5) (8), p.S83-S86
Main Authors: Umer, Masood, Khan Durrani, Muhammad Younus, Saeed, Javeria, Uddin, Nasir
Format: Article
Language:English
Subjects:
Adult
Cross-Sectional Studies
Female
Hospitals, University
Humans
Lymphoma - epidemiology
Lymphoma - therapy
Male
Middle Aged
Retrospective Studies
Tertiary Care Centers
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To determine the experience at the Aga Khan University Hospital in diagnosing and treating adult patients with primary lymphoma of bone. All patients with Primary lymphoma of bone (PLB) that were diagnosed and/or treated at Aga Khan University Hospital, Karachi from 2005 to 2019 were included as part of this study. There were 17 patients with PLB including 13 (76.5%) males and 4 (23.5%) females with a mean age of 44 ± 16.5 years. Nine patients were between 30-59 years of age at diagnosis. The mean follow-up time of patients was 80±46.7 months. Six patients had tumours of pelvic bone followed by tibia (5) and femur (4). Four patients had a pathological fracture at the time of presentation whereas 2 (11.8%) required surgical fixation of the pathological fracture. The stage of the tumour was based on Ann Arbor classification. Nine (52.9%) cases had Stage 1 disease, 7 (41.2%) had stage IV disease with metastasis in extra nodal tissues. As for treatment, every patient received chemotherapy whereas 5 (29.4%) received adjuvant radiotherapy. Complete remission in the size of the tumour was seen in 11 (64.7%) patients while 6 (35.3%) had partial remission. Post-treatment, 4 (23.5%) patients expired. The mean Overall Survival (OS) time was 80.18 ± 46.71months with a survival rate of 76.5. Primary lymphoma of the bone can be treated with medical regime and good prophylactic surgeries to avoid pathological fracture such as intramedullary nailing.
ISSN:0030-9982